Published on in Vol 13 (2024)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/49861, first published
.

Journals
- Alhejazi A, Alhuraiji A, Nourallah A, Alshehri A, Usman B, ElGohary G, Malhan H, Motabi I, Farsi K, Alshuaibi M, Diab M, Siddiqui M, Taha R, Abouzeid T, Ahmed W, Ali A, Ghonema R, Elkhazin S, Moussa Y, Alrajhi A, Rabea M, Aktham Y, Bawazeer N, Ali A, Chouikrat M. Analysis of pharmacotherapeutic approaches for multiple myeloma and correlated renal and pulmonary impairments: a retrospective real-world registry study in the Greater Gulf Region (REPAIR Study). Frontiers in Oncology 2025;15 View
- Perrone V, Leogrande M, Giacomini E, Cappuccilli M, Degli Esposti L. Healthcare Costs and Treatment Patterns of Triplet Therapies in Relapsed/Refractory Multiple Myeloma: Real World Evidence from Italy. ClinicoEconomics and Outcomes Research 2025;Volume 17:495 View
